Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 2A2Q | P08709 | Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+ | |
| 2AER | P08709 | Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. | |
| 2B8O | P08709 | Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex | Coagulation factor VII light chain, Coagulation factor VII heavy chain (E.C.3.4.21.21), Tissue factor, inhibitor |
| 2C4F | P08709 | crystal structure of factor VII.stf complexed with pd0297121 | COAGULATION FACTOR VII PRECURSOR (E.C.3.4.21.21), TISSUE FACTOR PRECURSOR |
| 2EC9 | P08709 | Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 | |
| 2FIR | P08709 | Crystal structure of DFPR-VIIa/sTF | Coagulation factor VII Light chain (E.C.3.4.21.21), Coagulation factor VII Heavy Chain (EC 3.4.21.21), Tissue factor |
| 2PUQ | P08709 | Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor | |
| 2ZP0 | P08709 | Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine | |
| 2ZWL | P08709 | Human factor viia-tissue factor complexed with highly selective peptide inhibitor | |
| 2ZZU | P08709 | Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | |
| 3ELA | P08709 | Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor | |
| 3TH2 | P08709 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 3TH3 | P08709 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 3TH4 | P08709 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 4IBL | P08709 | Rubidium Sites in Blood Coagulation Factor VIIa | |
| 4YLQ | P08709 | Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor | |
| 4Z6A | P08709 | Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor | |
| 4ZMA | P08709 | Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor | |
| 5L0S | P08709 | human POGLUT1 in complex with Factor VII EGF1 and UDP | Protein O-glucosyltransferase 1 (E.C.2.4.1.-,2.4.2.26), Coagulation factor VII (E.C.3.4.21.21) |
| 6R2W | P08709 | Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor | |
| 8CN9 | P08709 | Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII | |
| 8JDK | P08708 | Structure of the Human cytoplasmic Ribosome with human tRNA Asp(ManQ34) and mRNA(GAU) | |
| 8JDL | P08708 | Structure of the Human cytoplasmic Ribosome with human tRNA Tyr(GalQ34) and mRNA(UAU) (non-rotated state) | |
| 8JDM | P08708 | Structure of the Human cytoplasmic Ribosome with human tRNA Tyr(GalQ34) and mRNA(UAU) (rotated state) | |
| 5UV8 | P08700 | Interleukin-3 Receptor Complex | |
| 5UWC | P08700 | Cytokine-receptor complex | |
| 6NMY | P08700 | A Cytokine-receptor complex | |
| 6YXK | P08670 | Crystal structure of ACPA 3F3 in complex with cit-vimentin 59-74 | |
| 4MCY | P08670 | Immune Receptor | |
| 4MCZ | P08670 | Immune Receptor | |
| 4MD0 | P08670 | Immune Receptor | |
| 4MD5 | P08670 | Immune Receptor | |
| 4MDI | P08670 | Immune Receptor | |
| 4MDJ | P08670 | Immune Receptor | |
| 8TRQ | P08670 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
| 8TRR | P08670 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
| 8T5C | P08669 | Lassa GPC Trimer in complex with Fab 8.11G and nanobody D5 | |
| 6P95 | P08669 | Structure of Lassa virus glycoprotein in complex with Fab 25.6A | |
| 7S8H | P08669 | Structure of Lassa virus glycoprotein bound to Fab 18.5C and Fab 36.1F | |
| 7TYV | P08669 | Structure of Lassa Virus glycoprotein (Josiah) bound to Fab 25.10C | |
| 5VK2 | P08669 | Structural basis for antibody-mediated neutralization of Lassa virus | |
| 8EJD | P08669 | Structure of lineage IV Lassa virus glycoprotein complex (strain Josiah) | |
| 8EJH | P08669 | Lassa virus glycoprotein complex (Josiah) bound to 12.1F Fab | |
| 8EJI | P08669 | Lassa virus glycoprotein complex (Josiah) bound to 19.7E Fab | |
| 5FT2 | P08669 | Sub-tomogram averaging of Lassa virus glycoprotein spike from virus- like particles at pH 5 | PRE-GLYCOPROTEIN POLYPROTEIN GP COMPLEX |
| 7UOT | P08669 | Native Lassa glycoprotein in complex with neutralizing antibodies 8.9F and 37.2D | |
| 7UOV | P08669 | Native Lassa glycoprotein in complex with neutralizing antibodies 12.1F and 37.2D | |
| 7PVD | P08669 | Structure of the membrane soluble spike complex from the Lassa virus in a C1-symmetric map focused on the ectodomain | |
| 7PUY | P08669 | Structure of the membrane soluble spike complex from the Lassa virus in a C3-symmetric map | |
| 5LJX | P08668 | Structure of hantavirus envelope glycoprotein Gc in postfusion conformation in presence of 600 mM KCL |
